AI assistant
Sending…
Tempest Therapeutics, Inc. — Director's Dealing 2018
Dec 12, 2018
34632_dirs_2018-12-11_4d563e2d-72bb-42e8-9b11-e3ad45240210.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Millendo Therapeutics, Inc. (MLND)
CIK: 0001544227
Period of Report: 2018-12-07
Reporting Person: Hedley Mary Lynne (Director)
More from Tempest Therapeutics, Inc.
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
May 29
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 22
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 6
Regulatory Filings
2026
Apr 10
Regulatory Filings
2026
Apr 10
Regulatory Filings
2026
Mar 31